Video

Scrutiny Continues to Grow Around the Cost of Specialty Drugs

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Related Videos
Lipoprotein particles | Image Credit: © komgritch - stock.adobe.com
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Senior Doctor is examining An Asian patient.
Related Content
Osteoporosis, Biosimilar, Denosumab | Image Credit: © eddows | stock.adobe.com
December 2nd 2024

Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Lopez Island Pharmacy Exhibits a Lifelong Commitment to Community
November 29th 2024

Lopez Island Pharmacy Exhibits a Lifelong Commitment to Community

Karen Berger, PharmD
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Selma Mitchie, PharmD
November 21st 2024

Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop

Hidradenitis Suppurative, FDA, Dermatology, Bimzelx | Image Credit: © Gorodenkoff | stock.adobe.com
Published: November 20th 2024 | Updated: November 20th 2024

FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa

Ashley Gallagher, Associate Editor